Boehringer Ingelheim

Lilly's Heart Study Sets Up Showdown With Novo's Victoza
Bloomberg
Fri, 09/18/15 - 09:36 pm
Eii Lilly
Novo Nordisk
Victoza
Boehringer Ingelheim
diabetes
Jardiance
Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana
Fierce Pharma Marketing
Mon, 09/14/15 - 11:01 am
diabetes
FDA
Invokana
JNJ
Jardiance
Boehringer Ingelheim
Eli Lilly
Jardiance and its CV data? They're no knockout punch for stalwart Januvia, Merck says
Fierce Pharma
Wed, 09/2/15 - 10:27 am
Jardiance
diabetes
Eli Lilly
Boehringer Ingelheim
Merck
Januvia
Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?
Motley Fool
Sun, 08/30/15 - 11:54 am
Merck
clinical trials
Januvia
Janumet
Eli Lilly
Boehringer Ingelheim
SGLT2 inhibitor
Jardiance
Lilly, Boehringer amp up fight against Lantus with U.K. biosim launch
Fierce Pharma
Sat, 08/29/15 - 08:57 am
Lantus
Eli Lilly
biosimilars
diabetes
Boehringer Ingelheim
Sanofi
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
Yahoo/Reuters
Fri, 08/28/15 - 05:52 pm
FDA
diabetes
joint pain
DPP-4 inhibitor
Merck
Januvia
Onglyza
AstraZeneca
Takeda
Boehringer Ingelheim
Eli Lilly's Diabetes Drug May Halt Heart Disease
Motley Fool
Fri, 08/28/15 - 08:18 am
Eli Lilly
Jardiance
stroke
diabetes
Boehringer Ingelheim
Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Bloomberg
Fri, 08/21/15 - 05:24 pm
Merck
Januvia
Janumet
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
Yahoo/Reuters
Thu, 08/20/15 - 08:26 am
Eli Lilly
Boehringer Ingelheim
Jardiance
Will pricey new drug classes take the wind out of diabetes launches?
Fierce Pharma Marketing
Wed, 08/19/15 - 10:01 am
diabetes
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
Sanofi
Boehringer takes a neuroscience approach to obesity with latest deal
Fierce Biotech
Thu, 08/13/15 - 02:46 pm
obesity
Boehringer Ingelheim
Circuit Therapeutics
Boehringer bets up to $730M on a new lung cancer drug
Fierce Biotech
Wed, 07/29/15 - 09:49 pm
Boehringer Ingelheim
Hanmi Pharmaceutical
lung cancer
HM61713
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
Yahoo/Reuters
Tue, 07/28/15 - 10:04 am
Hikma
Boehringer Ingelheim
generics
M&A
Top 10 pharma companies in social media
Fierce Pharma Marketing
Mon, 07/20/15 - 09:12 am
social media
Boehringer Ingelheim
Bayer
Novartis
JNJ
Merck
Abbott Labs
GSK
Roche
Novo Nordisk
AstraZeneca
Boehringer gets respiratory boost with batch of Spiolto nods in EU
Fierce Pharma
Fri, 07/3/15 - 07:49 pm
Boehringer Ingelheim
Europe
Spiolto
COPD
Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt
Fierce Pharma
Tue, 06/30/15 - 11:14 am
Boehringer Ingelheim
generics
Hikma
Mallinckrodt
Perrigo Company
M&A
Boehringer says Pradaxa blood-thinning effect shown to be reversible
Yahoo/Reuters
Mon, 06/22/15 - 10:39 am
Boehringer Ingelheim
Pradaxa
stroke
blood thinners
Boehringer faces uphill battle for Stiolto, thanks to payer arm-twisting
Fierce Pharma Marketing
Wed, 06/3/15 - 07:38 pm
Stiolto Respimat
payer negotiation
Boehringer Ingelheim
Large U.S. cancer trial to match genetic glitches to targeted drugs
Yahoo/Reuters
Mon, 06/1/15 - 07:49 pm
clinical trials
Pfizer
Xalkori
Boehringer Ingelheim
Gilotrif
Roche
Kadcyla
AZD9291
AstraZeneca
VS-6063
Verastem
personalized medicine
Boehringer snags FDA approval for COPD combo drug
Fierce Biotech
Tue, 05/26/15 - 10:11 am
FDA
Boehringer Ingelheim
COPD
Stiolto Respimat
Spiriva
Striverdi

Pages